| |
|
|
|
SC Pharmaceuticals Inc  
|
|
6.545 -0.045 (-0.01%) |
01-21 13:05 |
|
Open: |
6.65 |
Pre close: |
6.59 |
Target:
|
7.84
|
|
High: |
6.65 |
Low: |
6.335 |
Resistance:
|
6.71
7.84
|
|
Volume: |
73,433 |
Market Cap: |
179M |
Support:
|
5.78
5.21
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.41
 |
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
5.97 |
Signal(12,26,9): |
-0.21 |
|
MA(100): |
7.60  |
Stochastic Oscillator |
%K(14,3):
|
92.41 |
|
MA(250): |
7.97 |
%D(3): |
85.34 |
|
Average Volume(K) |
3-Month: |
15097
|
52-Week |
High:
|
11.99 |
|
10-Days: |
11313 |
Low: |
5.00 |
|
RSI |
RSI(14):
|
54.03 |
Change(%): |
12.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.570 |
Return on Equity (ttm) |
-47.7 |
Shares Out. (M) |
27.32 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-22.3 |
Shares Float (M) |
8.18 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.51 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
65.77 |
|
Forward EPS |
-1.770 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
191 |
|
Book Value (p.s.) |
3.290 |
EBITDA (p.s.) |
-1.327 |
P/E |
-4.16 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.98 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-33.35 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-22.58 |
P/CF |
-5.35 |
|
|
|
|
|
|
